Sign in
4

Changes in Ownership

10x Genomics, Inc. Filed Acc 0001209191-21-012038

Director sold 7,500 shares at an average $193.00 ($1,447,516)

From the SEC's structured data for this filing

Trades in this filing

STUELPNAGEL JOHN R · Director

Table I: Non-derivative

9 lines
Date Transaction Shares Price Value Owned after D/I
2021-02-16 Sale : show line 1 in the form −400 $189.51 $75,802 465,591 D
2021-02-16 Sale : show line 2 in the form −1,400 $190.42 $266,582 464,191 D
2021-02-16 Sale : show line 3 in the form −2,683 $191.63 $514,140 461,508 D
2021-02-16 Sale : show line 4 in the form −451 $192.61 $86,869 461,057 D
2021-02-16 Sale : show line 5 in the form −600 $194.60 $116,760 460,457 D
2021-02-16 Sale : show line 6 in the form −800 $195.43 $156,345 459,657 D
2021-02-16 Sale : show line 7 in the form −633 $197.36 $124,929 459,024 D
2021-02-16 Sale : show line 8 in the form −233 $198.08 $46,153 458,791 D
2021-02-16 Sale : show line 9 in the form −300 $199.78 $59,935 458,491 D
Open-market sales · 7,500 sh · avg $193.00 · $1,447,516
Loading xslF345X03/doc4.xml…